Dyne Therapeutics, Inc.
DYN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818794
In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Dyne Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 90 | 102 | +12 |
| Shares | 46.7M | 44.6M | −2.12M (−4.5%) |
| Value | $320.7M | $565.8M | +$245.1M (+76.4%) |
New holders (26)
Institutions that held Dyne Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (14)
Institutions that held Dyne Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ra Capital Management, L.P. | 2,805,045 | $19.3M |
| Woodline Partners LP | 666,997 | $4.58M |
| EcoR1 Capital, LLC | 215,000 | $1.48M |
| Balyasny Asset Management LLC | 98,866 | $679.0K |
| Bank of Montreal | 41,304 | $290.0K |
| First Trust Advisors LP | 36,984 | $254.0K |
| Summit Rock Advisors, LP | 34,887 | $240.0K |
| Gsa Capital Partners LLP | 15,996 | $110.0K |
| Quantbot Technologies LP | 2,100 | $14.0K |
| Spire Wealth Management | 400 | $3.00K |
| Nisa Investment Advisors, LLC | 347 | $2.00K |
| Point72 Hong Kong Ltd | 132 | $1.00K |
| Meeder Asset Management Inc | 4 | $0 |
| Simplex Trading, LLC | 37 | $0 |